Clinical trial
Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
NCT01013181 is registered in ClinicalTrials.gov with Henri Mondor University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
- Lead sponsor
- Henri Mondor University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- August 31, 2009
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
thrombopenia